FedEx Corp (NYSE:FDX, ETR:FDX) suspended its financial outlook for fiscal 2026 on Tuesday, citing persistent uncertainty in global demand, even as the delivery giant reported stronger-than-expected results for the fourth quarter of fiscal 2025.
Adjusted earnings per share for the quarter came in at $6.07, beating the consensus estimate of $5.81, while revenue rose to $22.2 billion, topping forecasts of $21.8 billion.
Carnival PLC (LSE:CCL) and Carnival Corp (NYSE:CCL) shares rose 9% after the cruise operator said it exceeded its financial targets 18 months early and drummed up its highest ever level of customer deposits.
Adjusted return on invested capital and adjusted EBITDA per available lower berth day both reached the highest levels in nearly two decades, the FTSE 100 company said in a second-quarter update.
Uber Technologies Inc (NYSE:UBER, ETR:UT8) shares jumped more than 7% on Tuesday following the launch of a fully autonomous robotaxi service in Atlanta, integrating Waymo’s self-driving Jaguar I-PACE vehicles directly into the Uber app.
The service allows riders to be matched with driverless electric vehicles alongside traditional human-driven rides.
Immunic Inc (NASDAQ:IMUX) released new long-term data from an ongoing study showing that its experimental drug, vidofludimus calcium, continues to help patients with relapsing-remitting multiple sclerosis (RRMS) over time.
The biotech company said 92.3% of patients remained free of 12-week confirmed disability worsening (CDW) and 92.7% free of 24-week CDW at week 144, based on data representing roughly 952 cumulative treatment years.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced that its wholly owned subsidiary BUZZ High Performance Computing (BUZZ HPC) has launched a new NVIDIA Hopper GPU cluster in Quebec.
This marks one of three supercomputing clusters currently operated by the company across Canada and Sweden.
Candel Therapeutics Inc (NASDAQ:CADL) has announced a $15 million registered direct offering of common stock, the proceeds of which will support launch readiness, medical affairs, and pre-commercialization activities, as well as preparation for a Biologics License Application (BLA) submission for CAN-2409 in prostate cancer, expected in the fourth quarter of 2026.
“We are pleased to strengthen our financial position with the resources intended to support pre-commercialization and launch readiness activities for CAN-2409 in prostate cancer, pending regulatory approval, as well as other key corporate purposes,” Candel CEO Dr Paul Peter Tak said.
Shares in Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) rose 6% after the company announced a new commercial partnership with Ascend Imaging to boost US sales of its xenon-based MRI technology.
The agreement, covering four states, allows Ascend to act as an independent sales representative, helping expand Polarean’s footprint without growing its internal team.
The price of gold dropped 1.2% to a two-week low below $3,320 after Israel and Iran agreed to a ceasefire, following 12 days of fighting.
Gold has fallen around 2% over the past week, after gaining from safe haven demand in the past week amid an escalation of hostilities and missile strikes, culminating with US intervention in the form of 'bunker buster' bombs dropped on Iran's nuclear facilities over the weekend.